# PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)

> **NCT07683117** · NA · RECRUITING · sponsor: **EMPOWERX INC** · enrollment: 195 (estimated)

## Conditions studied

- HIV Prevention
- HIV Pre-exposure Prophylaxis
- Access and Linkage to Healthcare
- Technology Use

## Interventions

- **OTHER:** PEPPI Pharmacies

## Key facts

- **NCT ID:** NCT07683117
- **Lead sponsor:** EMPOWERX INC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2028-08
- **Final completion:** 2028-09
- **Target enrollment:** 195 (ESTIMATED)
- **Last updated:** 2026-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07683117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07683117, "PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07683117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*